Royalty Pharma Evrysdi royalty acquisition completed for $240M. RPRX now owns 100% of the tiered royalty on Roche's SMA drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback